Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FTXH vs. LOGSX: which is better?

Bottom line

FTXH vs LOGSX: the short answer

FTXH (First Trust Nasdaq Pharmaceuticals ETF) and LOGSX (Live Oak Health Sciences Fund) share a meaningful slice of their top holdings — about 41% by weight.

FTXH is cheaper at 0.6% vs 1.04% — a difference of $44 a year per $10,000 invested.

Over five years, LOGSX returned +8.1% a year vs +6.5% for FTXH.

Updated Nov 19, 2026

FTXH vs LOGSX side by side

FTXHLOGSX
TypeETFMutual fund
Fund familyFirst TrustOak Associates
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.6%1.04%
Annual cost per $10k$60$104
10-yr cost on $10k (prospectus)—$1,271
Max front loadNone—
12b-1 fee0%—
1-yr return+24.0%+19.6%
5-yr return (annualized)+6.5%+8.1%
10-yr return (annualized)—+7.3%
Best quarter+18.3%+13.4%
Worst quarter−17.4%−13.1%
Net assets (fund)$36.2M$56.1M
Number of holdings5128
Portfolio turnover35%24%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFTXHLOGSXDifference
2025+24.0%+19.6%+4.4%
2024+3.0%+0.2%+2.8%
2023−1.4%+1.2%−2.6%
2022+2.5%+3.7%−1.2%
2021+6.1%+17.5%−11.4%
2020+10.9%+6.0%+4.9%
2019+22.4%+19.0%+3.4%
2018−8.4%−4.0%−4.4%
2017+18.8%+13.4%+5.4%

Source: Fund prospectus bar charts

Holdings overlap

13 of FTXH's top 25 holdings also appear in LOGSX's top 25.

Shared top holdings
HoldingFTXHLOGSX
Eli Lilly & Company7.77%1.99%
Merck & Company Inc7.07%3.16%
Johnson & Johnson6.96%3.77%
Bristol-myers Squibb Company6.29%4.02%
Cardinal Health Inc3.53%5.86%
Vertex Pharmaceuticals Inc3.41%3.26%
Amgen Inc3.18%4.86%
Gilead Sciences Inc2.89%3.50%
United Therapeutics Corp2.72%5.11%
Regeneron Pharmaceuticals Inc2.72%4.43%
Incyte Corp2.39%3.30%
Exelixis Inc1.72%4.95%
Medpace Holdings Inc1.41%3.69%

Source: SEC Form N-PORT

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

FAQ

What is the difference between FTXH and LOGSX?
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and LOGSX (Live Oak Health Sciences Fund) share a meaningful slice of their top holdings — about 41% by weight. FTXH is cheaper at 0.6% vs 1.04% — a difference of $44 a year per $10,000 invested.
Which is cheaper, FTXH or LOGSX?
FTXH has the lower expense ratio (0.6%).
Should I own both FTXH and LOGSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.